News
Merck shares plunges after losing to Gilead
Merck & Co. fell after a federal judge tossed a record $2.54 billion verdict it had won against Gilead Sciences Inc. over a hepatitis...
News
SBRI invests £8.7 to help develop healthcare projects
GPs and general practices are under serious pressure through increasing workloads not least due to more complex cases and the health challenges of an...
Press Releases
FDA Approval for Allegra’s filing for supplemental new drug application LILETTA®
Allergan plc, a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to quality...
News
New prescriptions of Esyma are suspended by MHRA
In December, the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) started a review of the treatment for abnormal bleeding in women with uterine fibroids after...
Clinical Trials
Aimmune’s peanut succeeds at phase||| trials
U.S. drug developer Aimmune Therapeutics said on Tuesday its peanut allergy drug met the main goal of an eagerly awaited late-stage study, sending its...
Production & Manufacturing
Arix secures partnership with Ipsen
The deal gives Ipsen access to Arix’ network of professional and scientific advisors, and the chance to invest in the firm’s new and existing...
News
Richard Wolf Announces the Opening of New Office in Singapore
Richard Wolf, answering strong global demand for its high-performance endoscopic technology services, today announced plans to expand in Southeast Asia by opening its 15th...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read